Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Could Face 13% Funding Cut Under House FY '12 Appropriations Bill

Executive Summary

House Republicans' proposal to cut funding in the fiscal year 2012 Agriculture/FDA appropriations bill by 13% would cost FDA about $475 million if it applied across the board to both USDA and FDA.
Advertisement

Related Content

Collins Promises To Send NCATS Funding Proposal To Congress Within Weeks
Biosimilars: FDA Trying Group-Think Negotiating Strategy For User Fee
Generic User Fee Negotiators Struggling To Meet June Deadline
Generic User Fees Would Create 10-Month ANDA Review Time
FDA Budget To Rise By $418 Million In FY 11 As Congress Decides To Cut Spending Elsewhere
Hamburg Says Generic Drug Reviews Would Slow In Wake Of GOP-Backed Budget Cuts
FDA User Fees Soften Sting Of Second Round Of House Budget Cutting For 2011
FDA User Fees Soften Sting Of Second Round Of House Budget Cutting For 2011

Topics

Advertisement
UsernamePublicRestriction

Register

PS053398

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel